Prenatal DNA test may uncover Mom's cancer risk
NCT ID NCT04049604
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at pregnant women whose routine blood tests for the baby's DNA came back unusual or unclear. Researchers want to find out if these results can signal cancer in the mother. Participants will have imaging, lab tests, and surveys, and may be followed for up to 5 years. The goal is to better understand the link between these test results and cancer, not to provide a direct treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATERNAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States